US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 107.140
  • +1.130+1.07%
Close Jul 26 16:00 ET
  • 107.140
  • 0.0000.00%
Post 20:01 ET
1.92BMarket Cap19.99P/E (TTM)

Ligand Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ligand Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 6, 2024

Revenue(YoY)

32.75M

+24.20%
EPS(YoY)

0.43

+230.77%
Analyst Rating

Strong Buy

Jul 26, 2024

Ligand Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 38.592M--
Aug 6, 20242024/Q2-- / 32.746M--
May 7, 20242024/Q130.978M / 27.924M--
Feb 27, 20242023/Q428.101M / 25.645M--
Nov 8, 20232023/Q332.868M / 27.224M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 38.592M--
Aug 6, 20242024/Q2-- / 32.746M--
May 7, 20242024/Q130.978M / 27.924M--
Feb 27, 20242023/Q428.101M / 25.645M--
Nov 8, 20232023/Q332.868M / 27.224M--

Unlock Free Earnings Estimates

Ligand Pharmaceuticals Earnings Reports

  • 10-Q: Quarterly report

    May 8 17:27 ET

  • Ligand Pharmaceuticals | 10-K: Annual report

    Feb 29 22:53 ET

  • Ligand Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 17:03 ET

  • Ligand Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg